Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

LINEZOLID 600 MG TABLET

Linezolid
$2.0838per EA

Strength

600 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332018320

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/22/2022

Active Ingredients

LINEZOLID

Approval Type

Generic (ANDA)

FDA Application

ANDA205233

On Market Since

12/22/2015

Pharmacological Classes

Oxazolidinone Antibacterial
Oxazolidinones

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

-5.1%

All

-79.7%

Generic Alternatives

Save up to 32%

5 alternatives • Same active ingredient

LINEZOLID 600 MG TABLET
Generic
60687030921•American Health Packaging
$1.4257
Save 32%
LINEZOLID 600 MG TABLET
Generic
67877041984•Ascend Laboratories, LLC
$1.4257
Save 32%
LINEZOLID 600 MG TABLET
Generic
31722074920•Camber Pharmaceuticals Inc.
$1.4257
Save 32%
LINEZOLID 600 MG TABLET
Generic
00904655304•Major Pharmaceuticals
$1.4257
Save 32%
LINEZOLID 600 MG TABLET
Generic
64980056103•Rising Pharma Holdings Inc.
$1.4257
Save 32%

Related Drugs

Same classification

LINEZOLID 600 MG TABLET
Generic
59762130701•Mylan Pharmaceuticals Inc.
$1.4257
per EA
LINEZOLID 600 MG TABLET
Generic
59762130702•Mylan Pharmaceuticals Inc.
$1.4257
per EA
LINEZOLID 600 MG TABLET
Generic
62135044220•Chartwell RX LLC
$1.4257
per EA
LINEZOLID 100 MG/5 ML SUSP
Generic
00054031950•Hikma Pharmaceuticals USA Inc.
$2.1500
per ML
LINEZOLID 100 MG/5 ML SUSP
Generic
59762130804•Mylan Pharmaceuticals Inc.
$2.1500
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy